RxDoctor Payments Data

Allan Levi

Neurological Surgery · Miami, FLNPI 1386608016

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $59,055 of the $93,560 with a category attached, or 63.1%. Medtronic accounts for 87.9% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2021 at $32,682 and has fallen 95.4% since, to $1,496 in 2025.

$93,560in general payments, 2019–2025

Across 132 payments — averaging $708.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$82K
  • Integra Lifesciences Corporation$6K
  • Globus Medical$2K
  • Alphatec Spine, Inc$924
  • Astellas Pharma Inc$440
  • Spineology Inc.$291
  • plus $1K from 13 others
$1,671in research payments, 2019–2025

Across 1 payment — averaging $1670.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pacira Pharmaceuticals Incorporated$2K

What the payments were for

  • Consulting fees$23,54025%
  • Speaking & faculty fees$59,05563%
  • Travel & lodging$2,8703%
  • Food & beverage$8,0959%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$93,560 in reported general payments places this provider in the 85th percentile of 556 neurological surgery providers in Florida.

See all neurological surgery providers in Florida →

Medicare billing

Part B allowed, 2024
$386,524
Medicare patients
265
Services billed
683

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin94$1,083
Duloxetine Hcl16$624
Tizanidine Hcl29$335
Pregabalin22$300
Cyclobenzaprine Hcl28$252
Celecoxib21$227
Baclofen12$204
Methylprednisolone24$180
Methocarbamol16$170

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →